克劳丁-2通过调节抗体结合和补充激活来增强猪内皮细胞的人类抗体介导的补充依赖性细胞毒性
Weilong Li1, Fang Yang1, Dexin Yang1
1Department of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen Longhua District Key Laboratory for Diagnosis and Treatment of Chronic Kidney Disease, Shenzhen, Guangdong, China.
Frontiers in immunology
|March 5, 2025
概括
克劳丁-2通过增加人类抗体结合和猪内皮细胞中的补充激活来增强异种移植排斥. 减少Claudin-2可能会改善猪对人类移植中的异种移植存活率.
科学领域:
- 移植免疫学 移植免疫学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 免疫排斥是异种移植的一个主要障碍,猪内皮细胞 (ECs) 作为主要障碍.
- 紧结蛋白对于EC屏障功能至关重要,在异种移植中具有需要进一步研究的作用.
- 克劳丁-2 是一种关键的紧结蛋白,研究了它对人类抗体介导的补充依赖性细胞毒性 (CDC) 的影响.
研究的目的:
- 调查Claudin-2在人类抗体介导的对猪内皮细胞 (ECs) 的补充依赖性细胞毒性 (CDC) 中的作用.
- 在异种移植模型中,确定Claudin-2表达是否影响抗体结合和补充激活.
- 评估针对Claudin-2的潜力,以改善异种移植的存活率.
主要方法:
- 在人体抗体介导的体外模型中使用了CDC来评估Claudin-2敲击和过度表达在猪大动脉和腹ECs中的影响.
- 流细胞计量量化了C3c,C9和C5b-9沉积,以及人类IgM和IgG与猪皮EC结合.
- 实时PCR测量了补体调节剂 (CD46,CD55,CD59,H因子,I因子) 的mRNA水平.
主要成果:
- 克劳丁-2的损失保护了猪ECs免受人类抗体介导的CDC的影响,而过度表达增加了细胞毒性.
- 克劳丁-2调节人体抗体结合和补充激活,在克劳丁-2丢失时,C3c,C9和C5b-9沉积的减少证明了这一点.
- 克劳丁-2表达水平没有影响关键补充调节者的mRNA表达.
结论:
- 克劳丁-2通过调节抗体结合和补体激活,特别是C5b-9复合体沉积来增强猪EC细胞毒性.
- 向克劳丁-2 呈现了一个潜在的策略,以减少猪对人类异种移植中的免疫排斥.
- 在转基因猪中减少Claudin-2可能会提高异种移植的存活率.
相关概念视频
Antibody Actions
1.0K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.0K
Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K


